Transition From Adolescents to Adulthood for Patients With Congenital Heart Diseases
Primary Purpose
Congenital Heart Diseases
Status
Completed
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Therapeutic education
Standard follow-up
Sponsored by
About this trial
This is an interventional prevention trial for Congenital Heart Diseases
Eligibility Criteria
Inclusion Criteria:
- Patient from 13 years to 25 years inclusive.
- Carrying of Congenital Heart Disease as defined in the International Classification.
- Possible follow-up for one year on one of the three hospital center.
- Informed consent of the patient for adults and, parents or legal guardians for minors.
- Affiliation to a social security system.
Exclusion Criteria:
- Non-francophone,
- Severe intellectual impairment.
Sites / Locations
- Pediatric and Congenital Cardiology and Pulmonology Department, Arnaud De Villeneuve University Hospital
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
Therapeutic education
Control group
Arm Description
Structured therapeutic education programs
standard outpatient follow-up
Outcomes
Primary Outcome Measures
PedsQL 4.0 score
Evolution of the quality of life assessed by PedsQL 4.0 self-reported scores from month 0 to month 12.
Secondary Outcome Measures
Physiological parameters
Evolution of the physiological parameters during a cardiopulmonary exercise test performed on a treadmill according to a modified Bruce protocole. Evolution of the physiological parameters from month 0 to month 12
Ricci and Gagnon score
Evolution of the physical activity assessed by Ricci and Gagnon scores from month 0 to month 12. Ricci and Ganon score is a physical activity self-questionnaire with a total score out of 40 (<16 points: not very active, between 16 and 32 points: fairly active, > 32 points: very active).
Leuven Knowledge score
Evolution of the knowledge of the disease assessed by Leuven Knowledge scores from month 0 to month 12. The level of knowledge was assessed by the "transition readdiness assessment" instrument : 10-item questionnaire reflecting the basic knowledge of the diseases and its management.
Disease severity
The evolution of the severity of the disease from month 0 to month 12 was assessed by the degree of heart failure (NYHA functionnal class I to IV) and the number of hospitalizations (in stays and days) for complications related to the congenital heart disease
Anxiety and depression
The evolution of the levels of depression and/or anxiety from month 0 to month 12 was assessed respectively by :
the BDI (Beck Depression Inventory) for young adults
the CDI (Child Depression Inventory) for adolescents
the STAI (State and Trait Anxiety Inventory) for adults and STAI-C (Children) for adolescents.
A higher score is associated with a higher risk of depression/anxiety.
Full Information
NCT ID
NCT03005626
First Posted
December 26, 2016
Last Updated
December 13, 2022
Sponsor
University Hospital, Montpellier
1. Study Identification
Unique Protocol Identification Number
NCT03005626
Brief Title
Transition From Adolescents to Adulthood for Patients With Congenital Heart Diseases
Official Title
Transition From Adolescents to Adulthood for Patients With Congenital Patients With Congenital Heart Diseases: Impact of a Therapeutic Education Program on Quality of Life
Study Type
Interventional
2. Study Status
Record Verification Date
November 2022
Overall Recruitment Status
Completed
Study Start Date
January 2017 (Actual)
Primary Completion Date
November 16, 2020 (Actual)
Study Completion Date
November 16, 2020 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Hospital, Montpellier
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The Investigators aim to measure the impact of a transition program in congenital cardiology in terms of health-related quality of life.
Detailed Description
The number of adults with congenital heart diseases (CHD) is increasing. However, many young adults are lost to follow-up even in experienced tertiary care centers. American and European guidelines recommend to improve the management of young adults with CHD. Structured therapeutic education programs are therefore needed to optimize the transfer to adult healthcare. Our tertiary care CHD center recently implemented a transition program and simultaneously investigators decided to measure its impact. Indeed investigators need data from randomized trials in this filed. After previous controlled quality of life studies among children and adults with CHD, investigators chose to use the health-related quality of life (HR-QoL) as primary endpoint in this randomized study to focus on patient related outcomes.
The investigators assume that patients who participate in this program will improve their quality of life compared to controls. If investigators demonstrate the benefit of this program, it will have important consequences for patients with CHD and eventually for patients with other chronic medical conditions.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Congenital Heart Diseases
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
200 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Therapeutic education
Arm Type
Experimental
Arm Description
Structured therapeutic education programs
Arm Title
Control group
Arm Type
Active Comparator
Arm Description
standard outpatient follow-up
Intervention Type
Other
Intervention Name(s)
Therapeutic education
Intervention Type
Other
Intervention Name(s)
Standard follow-up
Primary Outcome Measure Information:
Title
PedsQL 4.0 score
Description
Evolution of the quality of life assessed by PedsQL 4.0 self-reported scores from month 0 to month 12.
Time Frame
Follow up of patients over 12 months
Secondary Outcome Measure Information:
Title
Physiological parameters
Description
Evolution of the physiological parameters during a cardiopulmonary exercise test performed on a treadmill according to a modified Bruce protocole. Evolution of the physiological parameters from month 0 to month 12
Time Frame
Follow up of patients over 12 months
Title
Ricci and Gagnon score
Description
Evolution of the physical activity assessed by Ricci and Gagnon scores from month 0 to month 12. Ricci and Ganon score is a physical activity self-questionnaire with a total score out of 40 (<16 points: not very active, between 16 and 32 points: fairly active, > 32 points: very active).
Time Frame
Follow up of patients over 12 months
Title
Leuven Knowledge score
Description
Evolution of the knowledge of the disease assessed by Leuven Knowledge scores from month 0 to month 12. The level of knowledge was assessed by the "transition readdiness assessment" instrument : 10-item questionnaire reflecting the basic knowledge of the diseases and its management.
Time Frame
Follow up of patients over 12 months
Title
Disease severity
Description
The evolution of the severity of the disease from month 0 to month 12 was assessed by the degree of heart failure (NYHA functionnal class I to IV) and the number of hospitalizations (in stays and days) for complications related to the congenital heart disease
Time Frame
Follow up of patients over 12 months
Title
Anxiety and depression
Description
The evolution of the levels of depression and/or anxiety from month 0 to month 12 was assessed respectively by :
the BDI (Beck Depression Inventory) for young adults
the CDI (Child Depression Inventory) for adolescents
the STAI (State and Trait Anxiety Inventory) for adults and STAI-C (Children) for adolescents.
A higher score is associated with a higher risk of depression/anxiety.
Time Frame
Follow up of patients over 12 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
13 Years
Maximum Age & Unit of Time
25 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patient from 13 years to 25 years inclusive.
Carrying of Congenital Heart Disease as defined in the International Classification.
Possible follow-up for one year on one of the three hospital center.
Informed consent of the patient for adults and, parents or legal guardians for minors.
Affiliation to a social security system.
Exclusion Criteria:
Non-francophone,
Severe intellectual impairment.
Facility Information:
Facility Name
Pediatric and Congenital Cardiology and Pulmonology Department, Arnaud De Villeneuve University Hospital
City
Montpellier
ZIP/Postal Code
34295
Country
France
12. IPD Sharing Statement
Citations:
PubMed Identifier
33468144
Citation
Werner O, Bredy C, Lavastre K, Guillaumont S, De La Villeon G, Vincenti M, Gerl C, Dulac Y, Souletie N, Acar P, Pages L, Picot MC, Bourrel G, Oude Engberink A, Million E, Abassi H, Amedro P. Impact of a transition education program on health-related quality of life in pediatric patients with congenital heart disease: study design for a randomised controlled trial. Health Qual Life Outcomes. 2021 Jan 19;19(1):23. doi: 10.1186/s12955-021-01668-1.
Results Reference
derived
Learn more about this trial
Transition From Adolescents to Adulthood for Patients With Congenital Heart Diseases
We'll reach out to this number within 24 hrs